Source: Press Release Rocket

Press Release: Amplyx Pharmaceuticals : Chemotherapy Induced Peripheral Neuropathy: Latest Pipeline Review H2 2016 with Detail Drugs Profile

Chemotherapy Introduced Peripheral Neuropathy Pipeline Review H2 2016 'Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2016', covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. It develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand [...]The post Chemotherapy Induced Peripheral Neuropathy: Latest Pipeline Review H2 2016 with Detail Drugs Profile appeared first on Press Release Rocket.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Ciara Kennedy's photo - President & CEO of Amplyx

President & CEO

Ciara Kennedy

CEO Approval Rating

89/100

Amplyx is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of fungal infections. Read more